Sign Up

BLFE

COM:BIOLIFESCIENCES

BioLife Sciences

  • Stock

USD

Market Cap

118

Beta: -

Volume Today

50

Avg: -

OverviewAnalysisMetricsFinancialsFilingsAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Nov '19
Nov '20
Nov '21
Nov '22
asset turnover
5.66
-
cash conversion cycle
-128.80
-
cash per share
0.00
-
0.00
76,663.51%
company equity multiplier
-0.01
-
-0.11
615.83%
days of inventory outstanding
days of payables outstanding
128.80
-
days of sales outstanding
dividend yield
ebit per revenue
-3.02
-
ebt per ebit
1.02
-
effective tax rate
enterprise value multiple
-47.17
-
fixed asset turnover
415.43
-
free cash flow per share
0.00
-
-0.02
1,956,241.62%
gross profit margin
-2.39
-
interest coverage
-25.21
-
inventory turnover
long term debt to capitalization
net income per ebt
1
-
1
0%
net profit margin
-3.08
-
operating cash flow per share
0.00
-
-0.02
1,954,118.14%
operating cycle
operating profit margin
-3.02
-
payables turnover
2.83
-
pretax profit margin
-3.08
-
price fair value
-3.15K
-
-84.85
97.31%
receivables turnover
return on assets
-66.71
-
-17.43
73.86%
return on capital employed
1.80
-
return on equity
0.98
-
1.84
87.08%
total debt to capitalization
-0.38
-

All numbers in USD (except ratios and percentages)